A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2314775C Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
11/28/2006	CA2311395C Flavivirus expression and delivery system
11/28/2006	CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/28/2006	CA2301185C Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
11/28/2006	CA2282394C Retroviral vectors, methods for their preparation and their use for gene transfer into cd4-positive cells
11/28/2006	CA2275379C Use of pramipexole in the treatment of restless legs syndrome
11/28/2006	CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/28/2006	CA2263379C Method for iron delivery to a patient by transfer from dialysate
11/28/2006	CA2256514C Veterinary use of a pleuromutilin derivative
11/28/2006	CA2239853C Indane dimer compounds and their pharmaceutical use
11/28/2006	CA2234609C 2-amino-6-anilino-purine derivatives and processes for their preparation
11/28/2006	CA2231562C Novel 5-o-deosaminyl 6-o-methyl erythronolide a derivatives, preparation method therefor and use thereof for preparing biologically active materials
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2222311C Use of at least one beta-adrenergic agonist as a p substance antagonist
11/28/2006	CA2216320C Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparation and use
11/28/2006	CA2200409C Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity
11/28/2006	CA2173582C Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
11/28/2006	CA2167525C Fungicidal methods and compositions for killing yeast and sporular microorganisms
11/28/2006	CA2164633C Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
11/28/2006	CA2160444C Aroyl-piperdine derivatives
11/28/2006	CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them
11/28/2006	CA2150945C Ibuprofen-containing effervescent pharmaceutical composition and process for preparing the same
11/28/2006	CA2137203C Protein kinase c inhibitors
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006125211A1 A1 adenosine receptor agonists
11/23/2006	WO2006125208A1 Inhibitors of matrix metalloproteinases
11/23/2006	WO2006125190A1 A1 adenosine receptor agonists
11/23/2006	WO2006125166A2 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
11/23/2006	WO2006125141A2 A method for the treatment of pompe disease using 1-deoxynojirimycin derivatives
11/23/2006	WO2006125132A2 Aerosolized fluoroquinolones and uses thereof
11/23/2006	WO2006125121A2 Antimicrobial composition comprising a cationic surfacant and an iodinated sulpone compound
11/23/2006	WO2006125119A1 Compositions and methods for treatment of eye disorders
11/23/2006	WO2006125073A2 Chemoprevention of colorectal cancer
11/23/2006	WO2006125049A2 Elastin producing fibroblasts
11/23/2006	WO2006125042A1 Method for the treatment of drug-induced sexual dysfunction
11/23/2006	WO2006125041A1 Method for the treatment of sexual dysfunctions due to medical conditions
11/23/2006	WO2006125016A1 Novel nsaids possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety
11/23/2006	WO2006124996A2 Inhibitors of polo-like kinase-1
11/23/2006	WO2006124961A2 Method of treating lymphangioleiomyomatosis (lam)
11/23/2006	WO2006124956A1 Compounds useful for treating neurodegenerative disorders
11/23/2006	WO2006124944A1 4, 6-diamino-[1,7] naphthyridine-3-carbonitrile inhibitors of tpl2 kinase and methods of making and using the same
11/23/2006	WO2006124923A1 Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
11/23/2006	WO2006124913A2 Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
11/23/2006	WO2006124898A1 Morphine sulfate formulations
11/23/2006	WO2006124890A1 Morphine sulphate formulations
11/23/2006	WO2006124887A1 Iminothiazolidinone derivatives as sfrp-1 antagonists
11/23/2006	WO2006124884A2 Dosing regimen
11/23/2006	WO2006124875A2 Diarylsulfone sulfonamides and use therof
11/23/2006	WO2006124874A2 Inhibitors of b-raf kinase
11/23/2006	WO2006124865A2 Biaryls derivatives useful as modulators of ion channels
11/23/2006	WO2006124863A2 Pyrrolopyridine derivatives as protein kinase inhibitors
11/23/2006	WO2006124862A2 Methods for the treatment of ocular and neurodegenerative conditions in a mammal
11/23/2006	WO2006124780A2 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
11/23/2006	WO2006124770A2 Treatment of sepsis and inflammation with alpha2a adrenergic antagonists
11/23/2006	WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	WO2006124744A1 Bicyclic derivatives as modulators of ion channels
11/23/2006	WO2006124739A1 The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders
11/23/2006	WO2006124731A2 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006124727A2 Compositions and methods useful in preventing cardiac hypertrophy
11/23/2006	WO2006124720A1 Multidrug resistant anticancer anthracyclines
11/23/2006	WO2006124713A2 4-biarylyl-1-phenylazetidin-2-ones
11/23/2006	WO2006124702A2 Methods and devices for non-invasive cerebral and systemic cooling
11/23/2006	WO2006124698A2 Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting
11/23/2006	WO2006124695A2 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives combined with another drug for lowering intraocular pressure
11/23/2006	WO2006124689A2 Combination therapy
11/23/2006	WO2006124676A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases associated with toll-like receptors
11/23/2006	WO2006124662A1 Il-12 modulatory compounds
11/23/2006	WO2006124609A2 Methods and compositions for treating arg
11/23/2006	WO2006124585A2 Multilayer drug system for the delivery of galantamine
11/23/2006	WO2006124581A2 Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists
11/23/2006	WO2006124573A2 Treatment of cancer with 2-deoxyglucose
11/23/2006	WO2006124523A1 Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor -(fish-r) antagonists
11/23/2006	WO2006124511A2 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth
11/23/2006	WO2006124506A2 Combination and use of drugs
11/23/2006	WO2006124494A1 TRANSITION-STATE INHIBITORS OF PIN1, α-KETOAMIDE-CONTAINING PEPTIDOMIMETICS, AND SYNTHESES THEREOF
11/23/2006	WO2006124462A2 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006124447A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	WO2006124413A2 Methods for treating drug resistant cancer
11/23/2006	WO2006124358A2 Method of treating a coccidioides infection by administering an ambruticin compound
11/23/2006	WO2006124354A2 Tyrosine kinase inhibitors
11/23/2006	WO2006124324A1 Therapeutic compositions and methods
11/23/2006	WO2006124275A2 Low dose administration of a topical composition
11/23/2006	WO2006124161A1 Sustained release l-arginine formulations and methods of manufacture and use
11/23/2006	WO2006124118A1 Diarylhydantoin compounds
11/23/2006	WO2006124062A1 Method for fostering bone formation and preservation
11/23/2006	WO2006124000A1 Aldehyde conjugated flavonoid preparations
11/23/2006	WO2006123953A1 Inhibitors of nucleoside phosphorylases and nucleosidases
11/23/2006	WO2006123827A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006	WO2006123792A1 Tri- or tetra-substituted-3-aminopyrrolidine derivatives
11/23/2006	WO2006123767A1 Method for producing asymmetric tetrasubstituted carbon atom-containing compound
11/23/2006	WO2006123766A1 Film coated preparation containing dextrose
11/23/2006	WO2006123765A1 Film coated preparation
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123699A1 Inducer of differentiation of stem cell into osteoblast
11/23/2006	WO2006123678A1 Stable tablet containing droxidopa
11/23/2006	WO2006123676A1 Prophylactic or therapeutic agent for corneal and conjunctival disorder
11/23/2006	WO2006123675A1 Protective agent for neurocyte comprising amidino derivative as active ingredient

1 ... 3992 3993 3994 3995 3996 3997 3998 3999 4000 4001 4002 4003 4004 4005 4006 4007 4008 4009 4010 4011 4012 ... 7860